Patents Assigned to Promethera Therapeutics SA
  • Patent number: 11339373
    Abstract: Novel adult liver progenitor cells (called H2Stem Cells) have been have been characterized on the basis of a series of biological activities and markers. Methods for producing H2Stem Cells allow providing such cells in the form of adherent cells and three-dimensional cell clusters in suspension that can be differentiated into cells having strong liver-specific activities and/or that can be used for treating liver diseases or for evaluating the efficacy, the metabolism, and/or toxicity of a compound.
    Type: Grant
    Filed: November 26, 2019
    Date of Patent: May 24, 2022
    Assignee: Promethera Therapeutics SA
    Inventors: Etienne Sokal, Sarah Snykers, Tuba Baran, Kris Gellynck, Luca Falciola